2-(3-Cyclopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

6-chloro-5-iodo-2-methyl-3,4-dihydropyrimidin-4-one, 97%, 500mg

4-Iododiphenyl ether, 98.0%, 10g

(S)-3-Aminohexanoic acid hydrochloride, 95.0%, 5g

((1r,4r)-4-((tert-butoxycarbonyl)amino)cyclohexyl)methyl methanesulfonate, 98%, 5g

4'-Chloro-2,2,2-trifluoroacetophenone, 95.0%, 1g

1-Acetyl-5-aminoindole, 95.0%, 1g

1-piperidin-4-ylpropan-1-ol, 95.0%, 10g

Óxido de silicio(IV) en polvo 99,99% -100 malla 50 g

N,N-Dimethylbenzamide>99.0%(GC)100g

(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzene, 98.0%, 5g

4,7-Dibromo-5,6-didodecoxy-2,1,3-benzothiadiazole, 97%, 1g

4-[3-(trifluoromethyl)phenoxy]aniline, 95%, 500mg